Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-29797

Single-particle
3.4 Å
EMD-29797
3D View Gallery
Deposition: 16/02/2023
Map released: 24/01/2024
Last modified: 30/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-29797
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 8g75 summary report (pdf.gz) Map and 8g75 FULL report (pdf.gz)
EMICSS annotations (xml)

SARS-CoV-2 spike/Nb4 complex with 2 RBDs up and 3 Nb4 bound

EMD-29797

Single-particle
3.4 Å
EMD-29797
3D View Gallery
Deposition: 16/02/2023
Map released: 24/01/2024
Last modified: 30/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Vicugna pacos
Sample: SARS-CoV-2 spike/Nb4 complex with 2 RBDs up and 3 Nb4
Fitted models: 8g75

Deposition Authors: Ye G, Bu F, Liu B , Li F
Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19.
Ye G, Pan R , Bu F, Zheng J, Mendoza A, Wen W, Du L , Spiller B, Wadzinski BE, Liu B , Perlman S , Li F
(2023) J Virol , 97 , e0144823 - e0144823
PUBMED: 37855638
DOI: doi:10.1128/jvi.01448-23
ISSN: 1098-5514
ASTM: JOVIAM